Cnot4 Het does not affect mRNA expression of metabolic genes as well as serum lipid levels or glucose tolerance. by Tomokazu Yamaguchi (8284989)

Subjects:

The relative importance by dominance analysis. by Lijuan Zhao (1387689)

Subjects:

Summary results of the samples. by Lijuan Zhao (1387689)

Subjects:

Description of digital inclusion. by Lijuan Zhao (1387689)

Subjects:

CSS data for this study. by Lijuan Zhao (1387689)

Subjects:

Cnot4 heterozygosity confers resistance to high fat diet-induced obesity. by Tomokazu Yamaguchi (8284989)

Subjects:

Cnot4 haploinsufficiency impairs rosiglitazone-induced transcriptional activity of PPAR by Tomokazu Yamaguchi (8284989)

Subjects:

The expression of tight junction proteins in intestinal wall. by Xueyan Lin (448667)

Subjects:

Cnot4 mediates differentiation into adipocytes from mouse embryonic fibroblasts. by Tomokazu Yamaguchi (8284989)

Subjects:

BAEP, cognitive function, and ammonia levels in four groups. by Xueyan Lin (448667)

Subjects:

Rifaximin and lactulose on inflammation in MHE rats. by Xueyan Lin (448667)

Subjects:

Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement by Juraj Velcicky (2201350)

Subjects:

Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement by Juraj Velcicky (2201350)

Subjects:

Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement by Juraj Velcicky (2201350)

Subjects:

(a, b). The statistical error analyses for the models using the same dataset. by Fahd Saeed Alakbari (10701871)

Subjects:

Visualization of DNA in an untreated ISP phage stock by immunogold labelling. by Saar Van Overfelt (20378458)

Subjects:

Experimental set up to determine the impact of DNase treatment of ISP phage stocks with different storage periods (ISP-1, ISP-2 and ISP-3) on the quantification with qPCR and the a... by Saar Van Overfelt (20378458)

Subjects:

Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

Subjects:

Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side. by Hyung Suk Yang (20442438)

Subjects:

Dose-response curve of the activity of chitosan solution (A), blank chitosan-TPP nanoparticles (B), AmB loaded chitosan-TPP nanoparticles (C) and AmB solution (pure) (D) against L. by Alaa Riezk (7037297)

Subjects: